Main clinical features: Xeroderma pigmentosum is a rare, recessive dis
order clinically characterized by extreme photosensitivity, pigmented
abnormalities of the skin-exposed areas, and frequent ocular and neuro
logical abnormalities. Xeroderma pigmentosum syndrome is associated wi
th an estimated 2000-fold increase in the risk to develop skin cancer
(basal cell carcinoma, squamous cell carcinoma and melanoma). A hetero
geneous disease: Skin or blood cells from Xeroderma pigmentosum patien
ts are hypersensitive to killing by ultraviolet and hypermutable after
ultraviolet C treatment. Cell fusion experiments based on complementa
tion of repair synthesis have recognized the presence of seven Xeroder
ma pigmentosum groups which exhibit various defects in the initial ste
ps of the DNA nucleotide excision repair pathway. A variant Xeroderma
pigmentosum form has been found to be normal in nucleotide excision re
pair but abnormal in a poorly to be normal in nucleotide excision repa
ir but abnormal in a poorly understood postreplication repair process.
Pathophysiology: The Xeroderma pigmentosum complementation groups dif
fer in terms of severity of clinical, cellular and genetic features. M
olecular and biochemical studies of the Xeroderma pigmentosum syndrome
have led to a better understanding of the mechanisms of ultaviolet-in
duced sensitivity and the mechanism of cancer development after ultrav
iolet exposure.